Mission Creek Capital Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$400K Buy
5,798
+43
+0.7% +$2.97K 0.09% 147
2025
Q1
$400K Buy
5,755
+105
+2% +$7.29K 0.1% 151
2024
Q4
$486K Sell
5,650
-12,712
-69% -$1.09M 0.11% 157
2024
Q3
$2.19M Buy
18,362
+395
+2% +$47K 0.51% 57
2024
Q2
$2.56M Buy
17,967
+6,525
+57% +$931K 0.65% 42
2024
Q1
$1.47M Buy
11,442
+3,620
+46% +$465K 0.38% 74
2023
Q4
$809K Sell
7,822
-100
-1% -$10.3K 0.21% 122
2023
Q3
$720K Sell
7,922
-660
-8% -$60K 0.24% 123
2023
Q2
$694K Sell
8,582
-1,978
-19% -$160K 0.22% 130
2023
Q1
$840K Sell
10,560
-110
-1% -$8.75K 0.29% 111
2022
Q4
$722K Sell
10,670
-950
-8% -$64.3K 0.26% 115
2022
Q3
$579K Sell
11,620
-200
-2% -$9.97K 0.22% 129
2022
Q2
$659K Hold
11,820
0.22% 127
2022
Q1
$656K Hold
11,820
0.18% 146
2021
Q4
$662K Sell
11,820
-400
-3% -$22.4K 0.13% 155
2021
Q3
$587K Sell
12,220
-480
-4% -$23.1K 0.11% 160
2021
Q2
$532K Sell
12,700
-200
-2% -$8.38K 0.09% 159
2021
Q1
$435K Hold
12,900
0.06% 168
2020
Q4
$451K Hold
12,900
0.14% 153
2020
Q3
$448K Sell
12,900
-144
-1% -$5K 0.18% 139
2020
Q2
$427K Sell
13,044
-950
-7% -$31.1K 0.22% 106
2020
Q1
$421K Sell
13,994
-200
-1% -$6.02K 0.23% 98
2019
Q4
$411K Buy
+14,194
New +$411K 0.19% 126